PDCD1 and malignant colon neoplasm: In this report, we present a rare case where a patient with MSS colon cancer that carried a somatic POLE mutation and hypermutated phenotype was treated with the programmed cell death 1 (PD-1) receptor inhibitor pembrolizumab.